Labiotech

The future of NSCLC treatment: what’s in store for the therapeutic space?
Source: Labiotech Published on 2025-04-30
Six biotech companies leading the charge in hemophilia treatment
Source: Labiotech Published on 2025-04-29
U.S. budget cuts: what is the impact on therapeutic research?
Source: Labiotech Published on 2025-04-28
The past, present, and future of genome sequencing
Source: Labiotech Published on 2025-04-25
AI in biotech today, and how it will impact the industry tomorrow
Source: Labiotech Published on 2025-04-25
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval
Source: Labiotech Published on 2025-04-23
Tariffs and trade war: A guide for expanding biotech business internationally
Source: Labiotech Published on 2025-04-22
Seven biotechs to watch in the hepatitis B space
Source: Labiotech Published on 2025-04-22
Biomaterials in construction: meet the startups reinventing our buildings
Source: Labiotech Published on 2025-04-17
HIV innovation: Six companies developing new treatments in 2025
Source: Labiotech Published on 2025-04-16
Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases
Source: Labiotech Published on 2025-04-16
The AI race in biotech: Is Europe falling behind the US and China?
Source: Labiotech Published on 2025-04-15
Metabolomics: The study of biology’s dark matter
Source: Labiotech Published on 2025-04-14
Basel: What’s behind the success of one of Europe’s leading biotech hubs?
Source: Labiotech Published on 2025-04-11
How nanobodies will revolutionize immunotherapy
Source: Labiotech Published on 2025-04-11